Baseclick
Private Company
Total funding raised: $7M
Overview
Baseclick is a privately-held, revenue-generating company based in Munich, Germany, that has established itself as a specialized provider of click chemistry-based tools for the life sciences sector. Its core business model combines the sale of proprietary reagents and kits with custom oligonucleotide synthesis and mRNA service offerings, catering primarily to research and diagnostic developers. The company leverages its in-house manufacturing and ISO-certified quality control to ensure fast delivery and reproducible results, as evidenced by its products being cited in over 300 peer-reviewed publications. Recent strategic moves, such as partnerships and conference presentations, indicate an expansion of its service offerings towards integrated oligonucleotide drug delivery solutions.
Technology Platform
Click chemistry (bioorthogonal, copper-catalyzed azide-alkyne cycloaddition) for site-specific modification and labeling of nucleic acids (DNA, RNA) and other biomolecules.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Baseclick competes in the life science reagents and tools market against giants like Thermo Fisher Scientific, Merck KGaA, and Revvity, as well as numerous specialized players in click chemistry (e.g., Click Chemistry Tools, Sigma-Aldrich offerings) and oligonucleotide synthesis/services (e.g., Integrated DNA Technologies, Eurofins Genomics, TriLink BioTechnologies). Its differentiation lies in its focused expertise in nucleic acid click chemistry, direct manufacturing control, and its evolving integrated service model with partners like metabion.